首页 › 基金 › Lynx1 Capital Management LP › DYN
Lynx1 Capital Management LP 对 DYN 的持仓历史
DYNE THERAPEUTICS INC · 医疗保健
Lynx1 Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 DYN(DYNE THERAPEUTICS INC)25,000 股,市值约 US$403K,约占其申报组合的 0.06%,在其申报持仓中市值排名第 21 位。 Lynx1 Capital Management LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Lynx1 Capital Management LP 对 DYN 的持仓演变
Lynx1 Capital Management LP 于 Q3 2026 首次披露 DYN 持仓:25,000 股(约 US$403K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 25.00K | $402.75K | 新进 |
关于 DYN 与 13F 数据
DYN(DYNE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 DYN,申报仓位最大的包括:Vestal Point Capital, LP (US$99.9M), TCG Crossover Management, LLC (US$74.3M), Frazier Life Sciences Management, L.P. (US$62.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DYN 的基金
- Vestal Point Capital, LP 6.20M 股 · $99.88M · Q3 2026
- TCG Crossover Management, LLC 4.62M 股 · $74.35M · Q3 2026
- Frazier Life Sciences Management, L.P. 3.85M 股 · $62.07M · Q3 2026
- FCPM III SERVICES B.V. 3.59M 股 · $57.78M · Q3 2026
- Atlas Venture Life Science Advisors, LLC 3.44M 股 · $55.43M · Q3 2026
- MPM BioImpact LLC 3.21M 股 · $51.68M · Q3 2026
- Logos Global Management LP 3.00M 股 · $48.33M · Q3 2026
- ARMISTICE CAPITAL, LLC 2.68M 股 · $43.14M · Q3 2026
- Sofinnova Investments, Inc. 2.51M 股 · $40.45M · Q3 2026
- Siren, L.L.C. 2.43M 股 · $39.13M · Q3 2026
- Venrock Adviser, LLC 2.17M 股 · $35.02M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.90M 股 · $30.61M · Q3 2026
更多关于 Lynx1 Capital Management LP
常见问题
How long has Lynx1 Capital Management LP held DYN?
Lynx1 Capital Management LP has disclosed DYN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Lynx1 Capital Management LP's current position in DYN?
As of Q3 2026, Lynx1 Capital Management LP holds 25.00K shares of DYN (DYNE THERAPEUTICS INC), valued at $402.75K, representing 0.06% of its reported portfolio and ranking #21.
Has Lynx1 Capital Management LP been buying or selling DYN?
In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP newly opened its position in DYN.
Which other funds hold DYN?
Other major institutional holders of DYN include Vestal Point Capital, LP, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.